3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Sell
12
ATNF Quote, Financials, Valuation and Earnings
Last price:
$1.59
Seasonality move
:
2.08%
Day range:
$1.53 - $1.68
52-week range:
$1.16 - $17.75
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.84x
Volume:
417.1K
Avg. volume:
733.8K
1-year change:
-54.81%
Market cap:
$3.1M
Revenue:
--
EPS (TTM):
-$4.81
Earnings Data
Next earnings date for ATNF
May 15
2025
Most recent earnings per share
-$0.85
Missed by $0.85
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ATNF Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 | -- | -- | -$0.85 | -- | -- |
| 08/12/2024 | Q2 | -- | -- | $0.01 | -- | -- |
| 05/15/2024 | Q1 | -- | -- | -$1.68 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$2.29 | -- | -- |
| 11/09/2023 | Q3 | -- | -- | -$24.53 | -- | -- |
| 08/09/2023 | Q2 | -- | -- | -$13.37 | -- | -- |
| 05/16/2023 | Q1 | -- | -- | -$24.15 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$206.87 | -$41.80 | -$165.07 |
| 11/15/2022 | Q3 | -- | -- | -$208.43 | -$41.80 | -$166.63 |
| 08/09/2022 | Q2 | -- | -- | $32.68 | -- | -- |
| 05/16/2022 | Q1 | -- | -- | $17.48 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | $19.76 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | $87.40 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$285.00 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$220.40 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$186.20 | -- | -- |
| 11/24/2020 | Q3 | -- | -- | -$19.00 | -- | -- |
| 08/20/2020 | Q2 | -- | -- | $7.60 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$53.20 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -- | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$3.80 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$0.97 | -- | -- |
180 Life Sciences Earnings Questions
-
How Much did 180 Life Sciences Generate in Revenue Last Quarter?
180 Life Sciences reported -- worth of top line sales in its most recent quarter.
-
Did 180 Life Sciences Beat Earnings Last Quarter?
180 Life Sciences announced earnings per share of -$0.85 which represents a miss of analyst forecast a -- per share.
-
Is 180 Life Sciences Profitable?
180 Life Sciences reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for 180 Life Sciences EPS Next Year?
180 Life Sciences's earnings are forecast to grow from -$52.59 per share to -- per share next year representing an increase of --.
-
When is 180 Life Sciences's Earnings Date?
180 Life Sciences's next earnings date is May 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 30.64% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is up 22.41% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is up 18.99% over the past day.
